MMG APPROACH

Lots of listening and not much talking – especially at first.

This kind of approach actually spurs creative thinking, which is a huge component of our overall strategy for patient recruitment and retention.

Why is creative thinking so important? For over 20 years, we’ve known that cookie-cutter approaches to patient recruitment simply don’t work. And because every trial is different, every trial needs its own unique strategy.

To create your unique strategy, MMG works with you in five planning areas:

• Protocol assessment
• Method selection
• Cost-benefit balance
• Implementation
• Refinement

Only MMG provides teams of experts across disease areas.  So we’ll understand each other, from the time we sit down with you to create a plan, throughout implementation and to the final objective.  We speak your language.

Once your plan is in place, we have all the in-house services you need to carry it out.

If you need help developing a recruitment strategy, or if your current program just isn’t working, contact us – give us a call at (301) 984-7191.

We’re ready to listen.

INDICATIONS Breast cancer, Cancer-related anemia, CINV, Colorectal cancer, Head & neck cancer, Melanoma, Non-Hodgkin’s lymphoma, Non-small cell lung cancer, Prostate cancer vaccine, Prostate cancer, Oral mucositis, Pancreatic cancer, Peripheral sensory neuropathy, T-cell lymphoma, NCI intramural trials, Alzheimer’s disease, Anxiety, Bipolar disorder, More...
COUNTRIES Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Estonia, Finland, France, Georgia, Germany, Guatemala, Greece, Honduras, Hong Kong, Hungary, India, Ireland, Israel, Italy, Jamaica, Japan, Latvia, Lithuania, Mexico, Morocco, Netherlands, New Zealand, Norway, Peru, Philippines, Poland, More...	John Benbrook President Case studies Publications Request a proposal